baber/WOPTO huggingface dataset:
Patent EP-0613708-B1 (EP)
Inventor: MARZLUF WERNER
IPC: B01D21/18
Filed: 1994-02-08
Granted: 1997-07-02
Abstract: A device for cleaning a basin, in particular for removing sludge (mud) or sand, which has a cleaning unit for taking up the materials to be separated off and for further conveyance to a transfer position for disposal and is also provided with a travel unit which is provided with a steering device and a drive for producing a travelling motion of the cleaning unit, is to be designed for achieving a simple construction and so as to be able to be matched for use in basins of various dimensions. This is achieved according to the invention by the moveable cleaning device (1) being provided with at least a first sensor (8) for recognising the amount and/or the location of the materials to be removed which are present, and by a computer unit (10) being present, which computer further processes output signals of the sensor (8) as control parameter for generating computer output signals for the steering device (7) to give a flexible travelling motion matched to the amount and/or the location of the materials present and by means of which the travel unit (3) can be moved in various directions. <IMAGE>
Patent EP-0622354-B1 (EP)
Inventor: FOSTER JAMES A
IPC: C07C231/02
Filed: 1994-04-27
Granted: 1999-06-02
Abstract: A process for the production of N-acylaminophenols by the concurrent hydrogenation of a nitrophenol to an aminophenol and the acylation of the aminophenol with acyl anhydride takes place on a continuous basis in a stirred tank reactor in which liquid product is continuously withdrawn from the reactor. Of particular interest is the manufacture of acetaminophen, N-acetyl-p-aminophenol by continuous reaction of p-ntirophenol, hydrogen and acetic anhydride.
Patent EP-0646784-B1 (EP)
Inventor: HOWARD III WILLIS E
IPC: G01N21/86
Filed: 1994-08-25
Granted: 2003-11-12
Abstract: A video test strip reader (10) uses a video imager or camera (12) for viewing a viewing field (14) containing reagent test strips (16) each having test pads (28) reacted with a specimen containing constituents of interest. The video imager produces an analog signal representing an image of the viewing field. An image handler (18) coupled to the video imager converts or digitizes the analog signal into a digital signal representing the image and stores the image in the form of an array of pixels representing the image. Each pixel contains color information broken down into red, green or blue (RGB). A processor (24) coupled to the image handler analyzes the array of pixels, determines the location and orientation of a test strip, identifies the test areas on the test strip, measures the corresponding test areas on the strip at the proper times and calculates the test results, such as the concentration of the constituents of interest in the specimen or other measurable properties of the specimen such as color or specific gravity, etc. Accordingly, the video test strip reader can simultaneously locate, color analyze and time track multiple test strips on the viewing field. <IMAGE>
Patent EP-0659025-B1 (EP)
Inventor: SILVERBERG MICHAEL DR
IPC: H04N11/16
Filed: 1994-12-16
Granted: 1998-09-16
Abstract: The transmitter has a signal source (1) providing television signals with an image ratio of 16:9 and a second source (2) providing television signals with a ratio of 4:3, each coupled to a mixer (6) receiving further inputs from an image format converter (3, 4, 5) of a letterbox coder. A colour modulator (8) is inserted between the output of the mixer and an identification signal insertion stage (9). Pref. the image format converter allows the edge line signals to be replaced by black level signals.
Patent EP-0653443-B1 (EP)
Inventor: COLLETTE HERVE
IPC: C08F4/60
Filed: 1994-10-27
Granted: 1998-01-28
Abstract: Catalyst system usable for the polymerisation of alpha-olefins, including     (a) a catalytic solid based on titanium trichloride (TiCl3), (b) a nonhalogenated cocatalyst including at least one nonhalogenated organoaluminium compound, characterised in that the nonhalogenated cocatalyst additionally contains at least one aminoalane containing no active hydrogen.   Such a catalyst system may additionally contain a third constituent chosen from the organic oxygen compounds of silicon.
Patent EP-0669929-B1 (EP)
Inventor: LYMAN STEWART
IPC: C07K16/24
Filed: 1993-11-15
Granted: 2007-01-03
Abstract: Antibodies to elk ligand (elk-L) polypeptides as well as DNA sequences, vectors and transformed host cells useful in providing elk-L polypeptides. The elk-L polypeptide binds to a cell surface receptor that is a member of the tyrosine kinase receptor family.
Patent EP-0762860-B1 (EP)
Inventor: HANSEN HENRIK CHRISTIAN
IPC: A61L15/58
Filed: 1994-01-14
Granted: 1997-12-17
Abstract: The skin plate product according to the invention is an adhesive, flat skin plate product for use as a semi-manufacture in the production of dressings, skin and wound care devices, fastening means for dressings, ostomy equipment, wound drains and catheters for incontinence equipment, in particular for men, and for use in electrodes for application to the skin, the said skin plate product having an area being delimited by the periphery of the product, and a first surface and a second surface consisting of two or more essentially non-mixed material units (1, 1', 2, 2', 2a, 2b, 2c, 4, 11, 12, 21, 21', 22, 22', 31, 32, 33, 41, 42, 43), at least two material units being of different material, of which at least one material unit is a skin friendly self-adhesive material, and where a first material unit (1, 1', 11, 21, 21', 31, 41) extends throughout the area of the entire product, this material unit further constituting at least a portion of the first surface (6, 26, 26', 36, 46) and the second surface (5, 25, 25', 35, 45), respectively, and the additional material unit or units constituting the other portion of the first and the second surface, respectively, and having a thickness which extends at least somewhat into the thickness of the product in a direction which intersects the first or second surface of the product.
Patent EP-0650387-B1 (EP)
Title: Dispositif permettant de fixer des roulettes sur des patins dont les roulettes sont alignees sur une rangee
Inventor: PERNER JOHANN
IPC: A63C17/06
Filed: 1994-05-09
Granted: 1996-10-09
Abstract: L'invention concerne un dispositif permettant de fixer des roulettes (4) sur des patins dont les roulettes sont alignées sur une rangée (1). L'axe des roulettes (4) traverse des découpes pratiquées dans un châssis (3) et se trouve dans un châssis intermédiaire (6). La largeur intérieure des découpes (14) pratiquées dans le châssis (3) est supérieure au diamètre extérieure des axes (7) et le châssis intermédiaire (6) peut être relié au châssis (3) à au moins deux hauteurs différentes. Le châssis intermédiaire (6) peut être fixé par liaison de force et de forme dans à moins deux hauteurs différentes, au moyen d'une goupille (10) qui traverse le châssis (3) et les bords libres du châssis intermédiaire (6), ce qui permet de fixer aisément sur le châssis au moins quelques roulettes à des hauteurs différentes, sans qu'il soit nécessaire de recourir à des outils spéciaux.
Patent EP-0703989-B1 (EP)
Inventor: JALKANEN SIRPA
IPC: C12R1/91
Filed: 1994-06-16
Granted: 1997-11-05
Abstract: CD44 is a family of glycoproteins involved in cell-cell and cell-matrix interactions. In addition to the major 90 kD form present on most hematopoietic cells, larger forms are found on keratinocytes and carcinoma cell lines. These bigger isoforms of CD44 arise by alternative splicing that results in insertion of one or more of the "variant" exons into the extracellular part of the 90 kD constant form of the molecule. Antibodies were raised against a synthetic peptide containing a sequence encoded by the human exon 6A mAb thus obtained (designated Var3.1) strongly reacted with the plasma membranes of squamous cells in upper layers of skin and tonsil surface epithelia. Weaker staining was seen in germinal centers, vascular endothelia and enterocytes. CD44v6 was absent from tissue leukocytes and connective tissue components. In comparison, Hermes-3 epitope (on the constant part) containing forms of CD44 were preferentially localized in basal layers of epithelia, present on the surface of most leukocytes and connective tissue cells, and undetectable on the luminal surface of high endothelial venules. In benign neoplasms, epithelial cells stained with mAb Var3.1 like in normal tissues. In contrast, immunostaining of 30 squamous carcinoma specimens (both primary and metastatic lesions) revealed that malignant transformation resulted in down-regulation or disappearance of Var3.1 epitope, but in majority of cases, not in diminished expression of the Hermes-3 epitope. An examination of serum samples from normal individuals and from patients with inflammatory diseases indicated that CD44v6 was increased in samples from patients with rheumatoid arthritis or inflammatory bowel disease.
Patent EP-0716149-B1 (EP)
Inventor: SHIGENOBU KAYOKO
IPC: G01N33/84
Filed: 1994-08-22
Granted: 2002-11-20
Abstract: The present invention relates to a method of quantitative determination of sodium ions in a sample using  beta -galactosidase, wherein the  beta -galactosidase reaction is conducted in the presence of at least one chelating agent selected from the group consisting of 1,2-cyclohexanediamine-N,N,N',N'-tetraacetic acid, ethylenediamine-tetraacetic acid, triethylenetetramine-hexaacetic acid, diethylenetriamine-N,N,N',N'',N''-pentaacetic acid, 1,3-diaminopropan-2-ol-N,N,N',N'-tetraacetic acid, ethylenediamine-N,N'-dipropionic acid dihydrochloride, ethylenediamine-tetrakis(methylenesulfonic acid), imino-diacetic acid, hydroxyimino-diacetic acid and nitrilo-triacetic acid. The method of quantitative determination of sodium ions of the present invention is useful in clinical examinations and the accuracy in the measurement by the method is high.
Patent EP-0708841-B1 (EP)
Inventor: ABKEN HINRICH JOHANN
IPC: C12Q1/6886
Filed: 1994-07-13
Granted: 1999-11-10
Abstract: The invention addresses DNA-protein-complexes, proteins, DNA sequences and antibodies that are suitable for the detection of cells with an unlimited proliferation and tumor-formation potential. The invention further addresses methods for obtaining such proteins or DNA sequences and methods for identifying animal and human cells with with an unlimited proliferation and tumor-formation potential using such proteins, DNA sequences or antibodies.
Patent EP-0714403-B1 (EP)
Title: Aqueous multiple-phase isolation of polypeptide
Inventor: BUILDER STUART
IPC: C07K14/61
Filed: 1994-08-10
Granted: 1998-06-10
Abstract: A method is described for isolating an exogenous polypeptide in a non-native conformation from cells, such as an aqueous fermentation broth, in which it is prepared comprising contacting the polypeptide with a chaotropic agent and preferably a reducing agent and with phase-forming species to form multiple aqueous phases, with one of the phases being enriched in the polypeptide and depleted in the biomass solids and nucleic acids originating from the cells. Preferably, the method results in two aqueous phases, with the upper phase being enriched in the polypeptide.
Patent EP-0700840-B1 (EP)
Inventor: HILMER GUENTER
IPC: B65F3/04
Filed: 1995-03-08
Granted: 1998-06-17
Abstract: The lifter incorporates a toggle lever (26). One lever end is fastened to the lifting frame (7) via a pivot joint (28), the other end is fastened to a clamp jaw (22) via another pivot joint (30). One end of a piston-cylinder drive (32) engages on a toggle joint (31) of the lever, which is located between the pivot joints. The toggle lever is angled when the clamp jaw is in open position, and is extended, when the jaw is in closed position. The piston-cylinder drive may have a power accumulator, which acts in the direction of the extended toggle lever position. The spring can consist of a pre-tensioned helical pressure spring (43).
Patent EP-0683173-B1 (EP)
Inventor: JONCZYK ALFRED DR
IPC: A61K38/00
Filed: 1995-04-26
Granted: 1999-08-11
Abstract: Cyclopeptides of formula (I), their salts and individual enantiomers or diastereomers are new: Cyclo(Arg-A-Asp-R1-R2) is (I); A is Gly or Ala; R1 is 2-carboxy-8-amino-4-thiapiperolidine-9-one (Btd); o-aminomethyl-o'-carboxybiphenyl (Biph); 2-aminomethyl-5-carboxymethyl-thiophene (Act); 6-aminohexanoic acid (Aha); 2-(1,7-diazaspiro(4,4)-nonan-7-yl)-4-methylpentanoic acid ((S,S)spiro-Pro-Leu); or 2-(3-amino-1-pyrrolide-2-onyl)-4-methylpentanoic acid ((S) or (R)Gly(ANC-2)-Leu) all these residues being bonded via peptide links; R2 is absent or is Val. (I) are inhibitors of integrins, esp. they inhibit interaction between  beta 3 or  beta 5 integrin receptors and ligands. They are useful, in human or veterinary medicine, for treatment or prevention of:(a) diseases of the circulation or bone (e.g. thrombosis, cardiac infarct, arteriosclerosis, inflammation, apoplexy, angina, osteoporosis, etc.) or (b) tumours. (I) also have antiviral and antimicrobial activity, e.g. for use as disinfectants for implants, catheters, etc. (I) can also be used to prepare immobilised ligands for purificn. of integrins by affinity chromatography. Dosage: 0.01-2 mg/kg/day, given orally, rectally, by injection or locally.
Patent EP-0687649-B1 (EP)
Inventor: BIRKENBEIL HANS
IPC: C01B15/023
Filed: 1995-05-10
Granted: 1998-01-14
Abstract: A method is shown for the separation of catalyst-free working solution from working solution, containing noble-metal black, especially palladium black as catalyst, of the hydrogenation cycle of the so-called anthraquinone method for the production of hydrogen peroxide by filtration of the catalyst-containing working solution using filter candles. The filter candles are formed of an open-pore support body based on a carbon material or metallic or ceramic material with an average pore width in a range of 5 to 100  mu m and of a single-layer or multi-layer membrane of ceramic material with an average pore width in a range of at least about 1 up to 10  mu m located on the outside surface of the support body.
Patent EP-0692348-B1 (EP)
Inventor: DE DOMPIERRE JEAN-BERNARD
IPC: B26D7/18
Filed: 1995-07-06
Granted: 1999-03-17
Abstract: The tool comprises a base plate (3) having openings (5), from the lower face (24) of which are fixed punches (4,4a). The openings are located along two orthogonal axes, one of which is inclined relative to one of the tool base plate edges at an angle between fifteen and twenty degrees. The tool works with a lower tool separating the cut-out sheets (2). The punches deform under the pressure engendered by downward displacement of the upper tool and meet a solid separation bar (9). One of the lateral faces of the punch section is tangent to one of the openings so that the pitch between the punches provides an identical total pressure from them, on the cut-out to be separated, near one lower tool separation bar, whatever the position occupied by the separation bars. The non-separated sheet has a front nipped piece (22) gripped by pincers (23) which transport this sheet to the cut-out separation and reception station. <IMAGE>
Patent EP-0712242-B1 (EP)
Inventor: TSURIA YOSSI
IPC: H04N7/16
Filed: 1995-11-09
Granted: 2002-02-06
Abstract: A television receiver assembly including a multi-channel television signal decoder (12) coupled to a source of incoming television signals (15), a multi-channel television display (14) coupled to the decoder for displaying received decoded television signals, a channel changing device operative to change the channel decoded by the decoder and displayed by the display, the channel changing device being inoperative to display received decoded television signals during a channel changing interval, and an interval message provider (28) operative to display at least one predetermined information message during the channel changing interval. <IMAGE>
Patent EP-0679841-B1 (EP)
Inventor: BEEKMAN ANTON
IPC: F23L17/14
Filed: 1995-04-25
Granted: 1997-10-15
Abstract: Assembly (2) of an air supply pipe (3) and a flue gas discharge pipe (4), suitable for connection to the air supply opening and flue gas discharge opening respectively of an essentially closed combustion furnace of, for example, a heating boiler or water heater, in which over at least a part of the length thereof the air supply pipe can run inside the flue gas discharge pipe, or vice versa, in which at the side facing away from the furnace said pipes end (6,7) at a distance from each other, related to the lengthwise direction of the pipes, and in which a covering element (9) covering the cross-section of the pipe is disposed at an axial distance from the opening of one of the pipes which faces away from the furnace, so that fluid flow between said covering element and the respective opening from the surroundings to the inside of the respective pipe and/or vice versa is permitted, while a collecting vessel element (12) with a periphery adapted to the covering element and coaxial therewith is provided, which collecting vessel element connects to one or both pipes, and is in fluid communication with the interior thereof. <IMAGE>
Patent EP-0722923-B1 (EP)
Inventor: ATTIG THOMAS G
IPC: C07C29/17
Filed: 1995-09-13
Granted: 1999-04-14
Abstract: Prodn. of tetrahydrofuran (THF) and 1,4-butanediol (BDO), contg. a major portion of BDO, comprises catalytic hydrogenation of an hydrogenatable precursor in contact with an H2-contg. gas and a carbon-supported Pd, Ag and Re-contg. hydrogenation catalyst prepd. by: i) impregnating the C support with a source of Pd, Ag and Re, in one or more steps, using at least one soln. of the metal sources; ii) drying the impregnated support to remove solvent after each impregnation step; iii) heating the impregnated support at 100-350 deg.C under reducing conditions.
Patent EP-0679098-B1 (EP)
Inventor: CLOKIE CAMERON MALCOLM LANG
IPC: A61F2/28
Filed: 1994-11-14
Granted: 2004-04-07
Abstract: A liquid composition comprising a transforming growth factor  beta  (TGF- beta ) in a liquid carrier which gels at about 37 DEG  C., promotes osseointegration of an implant in bone, when introduced into a bore in the bone, prior to insertion of the implant in the bone; a method of placing an implant in bone comprises injecting said liquid composition into a bore in the bone prior to insertion of the implant in the bore, the TGF- beta  being present in the liquid composition in a concentration effective in an interspace between an inner surface of the bore and an outer surface of the implant, to promote osseointegration.
Patent EP-0730736-B1 (EP)
Inventor: FLORION ANDRE
IPC: G01N33/18
Filed: 1994-11-18
Granted: 1997-07-09
Abstract: La demande concerne un procédé pour la surveillance biologique en temps réel de paramètres physico-chimiques des milieux aqueux utilisant des signaux électriques émis par des animaux-tests aquatiques électrogènes caractérisé en ce qu'il utilise les signaux émis par au moins un animal-test aquatique appartenant à l'ensemble (ondulatoire haute fréquence, pulsatoire régulier). La demande concerne également une installation pour la mise en ÷uvre du procédé. Application: surveillance des eaux de surface et des milieux aqueux en général.
Patent EP-0744080-B1 (EP)
Inventor: LINZENICH UWE
IPC: H01H71/46
Filed: 1995-01-13
Granted: 1998-11-11
Abstract: PCT No. PCT/DE95/00032 Sec. 371 Date Aug. 8, 1996 Sec. 102(e) Date Aug. 8, 1996 PCT Filed Jan. 13, 1995 PCT Pub. No. WO95/22161 PCT Pub. Date Aug. 17, 1995A low-voltage power switch with a relative auxiliary switch which is actuated as a signalling switch only when the generally multi-pole low-voltage power switch is triggered. The problem to be solved is that of controlling relative auxiliary switches simply and independently of the switch latch. To this end, the switch latch is designed in such a way that the included angle of the moveable contacts or the switching sprindle (18) is greater in the "triggered" than in the "off" state. A radial extension (60) is arranged on the switching spindle (18) in such a way that, in the "triggered" state, it engages a fixed pivoted lever (68) which itself is effectively connected to the prestressed actuating pushrod (66) of the relative auxiliary switch (56).
Patent EP-0804175-B1 (EP)
Inventor: GRADER LUDWIG
IPC: A61K9/70
Filed: 1995-01-05
Granted: 1998-11-25
Abstract: The present invention relates to a process and a device for the production of a flat administration form comprising a preparation that contains pharmaceutical active substances. The flowable preparation is conveyed to an applicator unit (12) by means of a metering pump, and flows through a distribution chamber (2) having a distribution plate (3) provided with passages (4). This application device (12) transfers the preparation onto a layer of the flat administration form (6,11) which is therefor contacted with the distribution plate (3) for a short time.
Patent EP-0743915-B1 (EP)
Inventor: ANDERSSON LOA
IPC: F16L57/00
Filed: 1995-02-09
Granted: 1999-11-17
Abstract: PCT No. PCT/SE95/00133 Sec. 371 Date Aug. 8, 1996 Sec. 102(e) Date Aug. 8, 1996 PCT Filed Feb. 9, 1995 PCT Pub. No. WO95/21777 PCT Pub. Date Aug. 17, 1995The invention relates to a method and an arrangement for closing of at least one end of a tube to protect the tube (8) against internal dirtying. According to the method, a strip (5) comprising a number of plugs (4) is fed up to a position in front of a tube (8) situated in a punch sleeve (9), at said position a plug (4) in the strip (5) is in a position just in front of the tube end (12), whereupon a punch (7) presses the strip (5) with the plug (4) against the tube (8) and the punch sleeve (9), so that the punch (7) in the end of its working stroke after pressing the plug (4) into the tube end (12) is punching out the plug (4) from said strip (5). The plug (4) formed for closing of a tube end is together with plugs, formed in the same way, integrally formed one after another at a predetermined distance in a longitudinal row in a continuous strip (5).
Patent EP-0748219-B1 (EP)
Inventor: GAZIT AVIV
IPC: G01N33/577
Filed: 1995-02-09
Granted: 2005-04-06
Abstract: La présente invention se rapporte à des molécules organiques susceptibles de moduler la transduction de signaux de tyrosine-kinase, et plus particulièrement à la transduction de signaux de récepteur KDR/FLK-1 (récepteur contenant le domaine d'insertion de kinase/kinase de foie f÷tal 1), afin de réguler et/ou moduler la vasculogenèse et l'angiogenèse. L'invention est en partie fondée sur le fait que, comme il a été démontré, l'expression du récepteur tyrosine-kinase KDR/FLK-1 est associée aux cellules endothéliales, ainsi que sur l'identification du facteur de croissance endothélial vasculaire (VEGF) comme ligand à haute affinité du récepteur FLK-1. Ces résultats indiquent que le récepteur KDR/FLK-1 a un rôle majeur à jouer dans le système de signalisation au cours de la vasculogenèse et de l'angiogenèse. La synthèse de cellules hôtes qui expriment le récepteur FLK-1, et les utilisations du récepteur FLK-1 exprimé pour évaluer et sélectionner des médicaments et des analogues de VEGF impliqués dans la modulation du récepteur FLK-1, soit par des activités agonistes soit par des activités antagonistes, sont également décrites. L'invention se rapporte également à l'utilisation des composés décrits pour traiter certaines affections, y compris le cancer, le diabète, les hémangiomes et le sarcome de Kaposi, qui sont associées à la vasculogenèse et à l'angiogenèse.
Patent EP-0757755-B1 (EP)
Inventor: GLEW WAYNE KENNETH
IPC: F02M7/24
Filed: 1995-04-21
Granted: 2001-07-11
Abstract: PCT No. PCT/AU95/00239 Sec. 371 Date Oct. 25, 1996 Sec. 102(e) Date Oct. 25, 1996 PCT Filed Apr. 21, 1995 PCT Pub. No. WO95/29335 PCT Pub. Date Nov. 2, 1995An IC engine fuel supply system (10) having a vaporization chamber (30) which has a foam mantle (48) for suspending fuel in a flow of air from a venturi inlet (72) for vaporizing the fuel. The vaporized fuel is mixed with the air in a mixing chamber (32) and then conveyed to an intake manifold of an IC engine. The system (10) improves the efficiency of the combustion of the fuel and reduces the amount of pollution produced.